Dementia and Geriatric Cognitive Disorders, 2025 Causal Relationship Between Inflammatory Proteins and Alzheimer's Disease: A Two-sample Bidirectional Mendelian Randomization Study Xu R., Gao Y. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
The Oncologist, 2025 First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors Powderly J., Gutierrez M., Balmanoukian A. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Signal Transduction and Targeted Therapy, 2025 Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis Liu X., Zhuang C., Liu L. et al. Olink Target 96OncologyImmunotherapyPathophysiologySerum | | | | |
Scientific Reports, 2025 Childhood obesity and insulin resistance is correlated with gut microbiome serum protein: an integrated metagenomic and proteomic analysis Liu L., Li M., Qin Y. et al. Olink Target 96Metabolic DiseasesPathophysiologySerum | | | | |
Brain, Behavior, & Immunity - Health, 2025 Bidirectional Mendelian randomization analysis of inflammatory factors and sleep related traits Liao Z., Guo S., Wang K. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
International Journal of Surgery, 2025 Plasma proteomics profiles predict the risk of future aortic aneurysm and aortic dissection Li M., He X., Gong W. et al. Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
Clinical Cancer Research, 2025 Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma Jang H., Patel M., Wang D. et al. Olink Explore HTOncologyImmunotherapyPathophysiologyPlasma | | | | |
Andrology, 2025 Maternal, childhood and adolescent influences on Leydig cell functional capacity and circulating INSL3 concentration in young adults: Importance of childhood infections and body mass index Ivell R., Tulumcu B., Alhujaili W. et al. Olink Target 96EndocrinologyPathophysiologyPlasma | | | | |
Cell Reports, 2025 Maternal obesity impairs fetal brown adipogenesis by attenuating fetal FGF21 signaling Hua L., Shen W., Gao D. et al. Olink Target 48 MouseMetabolic DiseasesPathophysiologyMouse Serum | | | | |
Diabetologia, 2025 Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes: differential associations with depressive symptom clusters Herder C., Zhu A., Schmitt A. et al. Olink Target 96Metabolic DiseasesNeurologyPathophysiologyPatient StratificationPlasma | | | | |
Hearing Research, 2025 Investigating the causal relationship between circulating inflammatory proteins and tinnitus: Insights from a Mendelian Randomization study He S., Wei M., Meng D. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Nature Communications, 2025 The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial Hansen J., Israelsen M., Nishijima S. et al. Olink Target 96HepatologyPathophysiologyPlasma | | | | |
The Oncologist, 2025 First-in-human phase I open-label study of the anti–TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors Gutierrez M., Tang S., Powderly J. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Clinical Kidney Journal, 2025 New biomarkers of inflammation associated to hemodialysis Guerrero F., Carmona A., Jiménez M. et al. Olink Target 96CVDNephrologyPathophysiologyPlasma | | | | |
Cardiovascular Diabetology, 2025 Single nuclei RNA-sequencing unveils alveolar macrophages as drivers of endothelial damage in obese HFpEF-related pulmonary hypertension Gorica E., Spezzini J., Papadopoulou I. et al. Olink Target 96 MouseMetabolic DiseasesCVDPathophysiologyMouse Serum | | | | |
Alzheimer's Research & Therapy, 2025 Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial Faridar A., Gamez N., Li D. et al. Olink Target 48NeurologyPathophysiologyPlasma | | | | |
World Journal of Otorhinolaryngology - Head and Neck Surgery, 2025 Integrative Analysis of Plasma Proteome and Genome Reveals Novel Drug Targets for Chronic Rhinosinusitis and Nasal Polyps Zhou E., Luo S., Xiao Y. et al. Olink Target 96Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Addiction Biology, 2025 Protein Associations With Alcohol Consumption and Genetic Risk for Alcohol‐Related Sociomedical Conditions Drouard G., Palviainen T., Kuo C. et al. Olink Explore 3072/384Other Diseases & SyndromesPathophysiologyPatient StratificationPlasma | | | | |
npj Precision Oncology, 2025 The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns Daher-Ghanem N., Sharon S., Tao D. et al. Olink Target 96OncologyImmunotherapyPatient StratificationTissue Supernatant | | | | |
RMD Open, 2025 Molecular insights into the relationship between sustained CRP elevation and endothelial dysfunction in axial spondyloarthritis Cuesta-López L., Arias-de la Rosa I., Martín-Salazar J. et al. Olink Target 96Immunological & Inflammatory DiseasesCVDPathophysiologySerum | | | | |